Issue Date: December 19, 2016
Bono and The Edge back healthy peptides
U2’s Bono is a fixture of rock music and philanthropy. He’s also an experienced investor in technology start-ups. He and bandmate The Edge have invested an undisclosed amount in Nuritas, a Dublin-based start-up that discovers peptide-based ingredients for use in nutraceuticals and cosmetics. The company finds its products by mining libraries of billions of food-derived molecules. It looks for peptides with anti-inflammatory, antimicrobial, and antiaging properties.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society